Prosecution Insights
Last updated: November 22, 2026
Application No. 18/590,499

COSMETIC AEROSOL PRODUCT

Non-Final OA §103
Filed
Feb 28, 2024
Priority
Mar 01, 2023 — EU 23159327.8
Examiner
BECKHARDT, LYNDSEY MARIE
Art Unit
1613
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Conopco, Inc. d/b/a Unilever
OA Round
1 (Non-Final)
28%
Grant Probability
At Risk
1-2
OA Rounds
1y 3m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants only 28% of cases
28%
Career Allowance Rate
160 granted / 575 resolved
-32.2% vs TC avg
Strong +48% interview lift
Without
With
+48.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
64 currently pending
Career history
666
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
47.7%
+7.7% vs TC avg
§102
9.8%
-30.2% vs TC avg
§112
23.6%
-16.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 575 resolved cases

Office Action

§103
DETAILED ACTION Claims 1-15 are currently pending. Claims 1-12 are currently under examination. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I in the reply filed on 09/02/2026 is acknowledged. Claim 13-15 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 09/02/2026. Applicant’s election without traverse of zinc neodecanoate in the reply filed on 09/02/2026 is acknowledged. No claims are withdrawn as a result of a species election. Priority The instant application claims priority to EP23159327.8, filed 03/01/2023. Information Disclosure Statement Applicant’s Informational Disclosure Statement, filed on 10/10/2024 and 08/25/2025 has been considered. Please refer to Applicant's copy of the 1449 submitted herein. Claim Objections Claim 2 is objected to because of the following informalities: Claim 2 contains the limitation “comprising fragrance” wherein the limitation should be “comprising a fragrance” for better readability. Appropriate correction is required. Claim 7 is objected to because of the following informalities: Claim 7 contains the abbreviation RTP and VTP which are not defined in the claims. It would be remedial to the full term in the claims, e.g. restricted tail piece (RTP) and Vapour phase tap (VPT) as defined in the instant specification (page 11, lines 1-5). Appropriate correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-2, 4-6 and 8-12 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2021/0369575 in view of US 6,581,807. Regarding claim 1, the limitation of a cosmetic aerosol product comprising a pressurized container holding a base composition and a propellant which is a mixture, wherein the pressurized containing comprising a pressure release valve, a reservoir containing all of the base compristion and all of the propellant and a dip tube arranged for the transport of the base composition from the reservoir to the pressure release value, wherein the base compristion comprises ethanol and a non-volatile, ethanol-soluble cosmetic active and the weight ratio of the based composition to the propellant is from 30:70 to 90:10 is met by the ‘575 publication teaches deodorizing composition comprising at least one zinc carboxylate salt in an anhydrous solvent (abstract). The active is taught to be the elected zinc neodecanoate [0027] at 4% [0052]. The solvent is taught to be ethanol [0057]. The product is in the form of an aerosol [0074]. The propellant is taught to include ethane, butane and combinations thereof and is present from 20-70% by weight of the composition [0085]. The deodorizing composition in aerosol format is filled into canisters capable of withstanding pressure generated by the composition wherein the canister is fitted with a dip tube, valve and spray nozzle through which the formation is dispensed [0098]. Exemplified compositions include 39% base composition and 60% propellant (Example 2). Regarding claim 2, the limitation of comprising a fragrance at a level of from 1 to 50% by weight of the base composition is met by the ‘575 publication teaching fragrance is present [0058] from 0.05-10wt% the total compositions [0080] wherein the base compristion is taught to be exemplified as 39% of the total composition, leading to 0.02 to 3.9% fragrance in the base composition. The fragrance level is taught as optimizable as it is present in an effective amount to provide the desired scent impression [0079]. Regarding claim 4, the limitation of the weight ratio of the base composition to the propellant is from 50:50 to 90:10 is met by the ‘575 publication teaching the propellant being present at 20-70% weight of the deodorizing compristion [0085], thus making the ratio of base composition to propellant 80:20 to 30:70, overlapping with the claimed range. In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claim 6, the limitation of wherein the liquified gas is selected from C3-C4 hydrocarbons is met by the ‘575 publication teaching the propellant including butane [0085]. Regarding claim 8-11, the limitation of wherein the cosmetic active is the elected zinc neodeconate is met by the ‘575 publication teaching the active is taught to be the elected zinc neodecanoate [0027] at 4% [0052]. The ’575 publication does not specifically teach a propellant which is a mixture of a compressed gas and a liquified gas as a weight ratio of from 0.1:99 to 10:90 (claim 1) wherein the compressed gas is nitrogen (claim 5). The ‘807 patent is directed to an aerosol product able to surely spray constant amount of an aerosol composition having an aerosol container having a liquid storage part in a passage from the interior of the container body to a nozzle of an aerosol valve system (abstract). The aerosol container comprises a container body charged with an aerosol composition, an aerosol valve system attached to an opening of the container rbody to open/close between the interior and the exterior of the container body and spraying part with a nozzle and further a liquid storage part (column 2, lines 25-37). The composition comprises alcohols such as ethanol (column 5, lines 5-10). The composition contains perspirant inhibitors and deodorant (column 5, lines 20-30). The invention comprises a liquified gas and a compressed gas combination wherein the compressed gas dissolved in the concentrate an the liquidized gas in the liquid storage part vaporizes to active aerosol composition wherein the liquid storage part is activated more strongly and sprayed further surely (column 6, lines 1-20). The liquefied gas propellant has a vapor pressure of 0.1 to 0.6 MPa and can be butane. The compressed gas can be carbon dioxide or nitrogen (column 6, lines 50-70). The liquefied gas is taught to be 30-99% by weight and the compressed gas is taught to be 0.1 to 10% by weight. When the amount of the compressed gas is more than 10% by weight, the pressure of the product is excessively increased to a dangerous degree (column 7, lines 10-30), thus teaching an overlapping ratio claimed and a reason to optimize the amount, to obtain the desired pressure of the product. The butane gas mixture is taught to have a vapor pressure of 0.3 MPa at 25 degrees C (column 7, lines 55-6) It would have been prima facie obvious to one of ordinary skill in the art before the filing date of the claimed invention to use the combination of liquified and compressed gas in the composition taught by the ‘575 publication because the ‘575 publication teaches a combination of propellants may be used including carbon dioxide and butane and the ‘807 patent teaches specific combinations of liquefied and gas propellants which include carbon dioxide/nitrogen and butane, thus it would have been prima facie obvious to one of ordinary skill in the art to use known combinations or propellants as taught by the ‘807 patent in the composition taught by the ‘575 publication. One of ordinary skill in the art before the filing date of the claimed invention would be motivated to use the combination of propellants as taught by the ‘807 patent because the ‘807 patent teaches the combination of propellants results in the liquid storage part vaporizes to active aerosol composition wherein the liquid storage part is activated more strongly and sprayed further surely. One of ordinary skill in the art before the filing date of the claimed invention would have a reasonable expectation of success in using the propellants of the ‘807 patent in the composition of the ‘575 publication as the ‘575 publication and the ‘807 patent are both directed to deodorant aerosol composition comprising propellants, wherein the propellants are taught to be overlapping ingredients, such as carbon dioxide and butane. Claim(s) 3 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2021/0369575 in view of US 6,581,807 as applied to claims 1-2, 4-6 and 8-12 above, and further in view of US 2008/0017671. As mentioned in the above 103 rejection, all the limitations of claims 1-2, 4-6 and 8-12 are taught by the combination of the ‘575 publication and the ‘807 patent. The combination of references does not specifically teach the pressure in the container, prior to the first use, is from 85 to 125 psig (0.59-0.86 MPa) at 25 degrees C (claim 3). The ‘671 publication teaches the use of compressed gas propellants in aerosol compositions. The aerosol composition may comprise antiperspirant [0042]. The pressure within the container used to deliver the composition is not to exceed 100 psig at 54 degrees c. A container having 90 psig at 21 degrees C is describe wherein the pressure is that of the container prior to first use [0075]. Over 52 weeks, with no use, the pressure dropped by 11 psig [0075]. Although the reference is silent regarding the pressure of the container being 85 to 125 psig at 25 degree C, it would have been obvious to modulate the pressure of the aerosol composition of the ‘575 publication and the ‘807 patent such that the contents could reliably be dispersed with such that the exiting of the composition was not over pressurized and is sufficiently pressured to be capable of dispensing with the entire contents of the container. It would have been prima facie obvious to one of ordinary skill in the art before the filing date of the claimed invention to use pressurized values that are capable of being stored in the container as taught by the ‘671 publication for the compressed propellant compositions as taught by the ‘575 publication. Claim(s) 7 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2021/0369575 in view of US 6,581,807 as applied to claims 1-2, 4-6 and 8-12 above, and further in view of US 2018/0311119. As mentioned in the above 103 rejection, all the limitations of claims 1-2, 4-6 and 8-12 are taught by the combination of the ‘575 publication and the ‘807 patent. The combination of references does not specifically teach wherein the pressure release valve comprises an RTP of from 0.5-1.0mm and a VTP of from 0.30 to 0.50 mm (claim 7). The ‘119 publication teaches an aerosol antiperspirant product (title) having good sustainability comprising an anhydrous composition comprising an aerosol dispenser comprising a container body, an aerosol valve and a valve actuator, comprising an antiperspirant active and the aerosol valve of the aerosol dispenser having a vapor phase tap to restrictive tailpiece ratio of from 0.6:1 to 1.2:1 (abstract). An essential feature of the invention is that the aerosol valve comprises a vapor phase tap to enable propellant from the headspace above the antiperspirant composition to enter a valve chamber and enhance spray formation and quality. The aerosol valve comprises a restricted tailpiece (RTP) to connect a dip tube going into the antiperspirant composition with the main valve housing and may be an integral part of the valve housing. The maximum diameter of the VPT is preferably less than 0.75 mm and more preferably less than 0.65 mm. The maximum diameter of the RTP is preferably less 0.8 mm and more preferably less than 0.7 mm ([0096]-[0098]). Propellants are taught to include butane [0085] wherein the compristion is a deodorant [0082]. It would have been prima facie obvious to one of ordinary skill in the art before the filing date of the claimed invention to use the RTP and VTP taught by the ‘119 publication for the aerosol container taught by the ‘575 publication because the ‘575 publication and the ‘119 publication are both directed to aerosol compositions which are deodorants wherein the container include a reservoir and dip tube to dispsen the composition. One of ordinary skill in the art before the filing date of the claimed invention would be motivated to use the RTP and VTP taught by the ‘119 publication for the container taught by the ‘575 publication because the ‘119 publication teaches the RTP and VTP to be essential components of the container where the container of the ‘119 publication is taught to enable propellant from the headspace above the antiperspirant composition to enter a valve chamber and enhance spray formation and quality, thus motivating one of ordinary skill in the art to use the RTP and VTP of the ‘119 publication for the container in the ‘575 publication. Conclusion No claims are allowed. Examiner Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to LYNDSEY MARIE BECKHARDT whose telephone number is (571)270-7676. The examiner can normally be reached Monday-Thursday 9am to 4pm and Friday 9am to 2pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Brian-Yong Kwon can be reached at 571-272-0581. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LYNDSEY M BECKHARDT/ Examiner, Art Unit 1613
Read full office action

Prosecution Timeline

Feb 28, 2024
Application Filed
Aug 24, 2026
Response after Non-Final Action
Oct 21, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758547
Long Acting Injectable Formulations
3y 5m to grant Granted Oct 13, 2026
Patent 12691199
MUSSEL-INSPIRED PHOTOREACTIVE INSTANT GLUE FOR ENVIRONMENTAL AND BIOMEDICAL APPLICATIONS
1y 7m to grant Granted Jul 28, 2026
Patent 12685803
Antimicrobial Polymer for Use in Ophthalmic implants
6y 1m to grant Granted Jul 21, 2026
Patent 12678453
Aerosolized Formulations of HIV Protease Inhibitors for the Treatment of Airway Reflux
3y 9m to grant Granted Jul 14, 2026
Patent 12673133
BIODEGRADABLE POLYMER FINE PARTICLE FOR FILLER, FREEZE-DRIED BODY INCLUDING THE SAME, MANUFACTURING METHOD THEREOF, AND FILLER INJECTION INCLUDING FREEZE-DRIED BODY
2y 5m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
28%
Grant Probability
76%
With Interview (+48.2%)
3y 11m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 575 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month